| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 2025 |
| 1 | OMEPRAZOLE MAGNESIUM | 137 |
| 2 | OMEPRAZOLE | 125 |
| 3 | ALBUTEROL SULFATE | 98 |
| 4 | BUDESONIDE | 84 |
| 5 | CETIRIZINE HYDROCHLORIDE | 80 |
| 6 | ERGOCALCIFEROL | 79 |
| 7 | MONTELUKAST SODIUM | 66 |
| 8 | PANTOPRAZOLE | 62 |
| 9 | ADALIMUMAB | 52 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USTEKINUMAB-AAUZ | 2 | 0.1176 |
| 1 | ANTACID CALCIUM CARBONATE | 1 | 0.0189 |
| 2 | DYCLONINE HYDROCHLORIDE | 1 | 0.0105 |
| 3 | VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) | 1 | 0.0065 |
| 4 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0058 |
| 5 | L-GLUTAMINE | 2 | 0.0055 |
| 6 | LEVONORGESTREL / ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | 1 | 0.0043 |
| 7 | DUPILUMAB | 2025 | 0.0039 |
| 8 | CHENODIOL | 1 | 0.0028 |
| 9 | ERGOCALCIFEROL | 79 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2025 |
| 1 | Proton Pump Inhibitor [EPC] | 181 |
| 2 | Corticosteroid [EPC] | 173 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 106 |
| 4 | Provitamin D2 Compound [EPC] | 79 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 73 |
| 6 | Anti-IgE [EPC] | 49 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 46 |
| 8 | Catecholamine [EPC] | 39 |
| 9 | alpha-Adrenergic Agonist [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 37 | 0.0538 |
| 1 | Human Antihemophilic Factor [EPC] | 1 | 0.0065 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2025 | 0.0039 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 8 | 0.0039 |
| 4 | Provitamin D2 Compound [EPC] | 79 | 0.0027 |
| 5 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 6 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 2 | 0.0012 |
| 7 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 8 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 9 | Antihypoglycemic Agent [EPC] | 4 | 0.0009 |